首页> 美国卫生研究院文献>Journal of Clinical Medicine >Renal Replacement Therapy: Purifying Efficiency of Automated Peritoneal Dialysis in Diabetic versus Non-Diabetic Patients
【2h】

Renal Replacement Therapy: Purifying Efficiency of Automated Peritoneal Dialysis in Diabetic versus Non-Diabetic Patients

机译:肾脏替代治疗:糖尿病和非糖尿病患者自动腹膜透析的净化效率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: In order to reduce the cardiovascular risk, morbidity and mortality of peritoneal dialysis (PD), a minimal level of small-solute clearances as well as a sodium and water balance are needed. The peritoneal dialysis solutions used in combination have reduced the complications and allow for a long-time function of the peritoneal membrane, and the preservation of residual renal function (RRF) in patients on peritoneal dialysis (PD) is crucial for the maintenance of life quality and long-term survival. This retrospective cohort study reviews our experience in automatic peritoneal dialysis (APD) patients, with end-stage renal disease (ESRD) secondary to diabetic nephropathy (DN) in comparison to non-diabetic nephropathy (NDN), using different PD solutions in combination. Design: Fifty-two patients, 29 diabetic and 23 non-diabetic, were included. The follow-up period was 24 months, thus serving as their own control. Results: The fraction of renal urea clearance (Kt) relative to distribution volume (V) (or total body water) (Kt/V), or creatinine clearance relative to the total Kt/V or creatinine clearance (CrCl) decreases according to loss of RRF. The loss of the slope of RRF is more pronounced in DN than in NDN patients, especially at baseline time interval to 12 months (loss of 0.29 mL/month vs. 0.13 mL/month, respectively), and is attenuated in the range from 12 to 24 months (loss of 0.13 mL/month vs. 0.09 mL/month, respectively). Diabetic patients also experienced a greater decrease in urine output compared to non-diabetic, starting from a higher baseline urine output. The net water balance was adequate in both groups during the follow up period. Regarding the balance sodium, no inter-group differences in sodium excretion over follow up period was observed. In addition, the removal of sodium in the urine output decreases with loss of renal function. The average concentration of glucose increase in the cycler in both groups (DN: baseline 1.44 ± 0.22, 12 months 1.63 ± 0.39, 24 months 1.73 ± 0.47; NDN: baseline 1.59 ± 0.40, 12 months 1.76 ± 0.47, 24 months 1.80 ± 0.46), in order to maintain the net water balance. The daytime dwell contribution, the fraction of day and the renal fraction of studies parameters provide sustained benefit in the follow-up time, above 30%. Conclusions: The wet day and residual renal function are determinants in the achievement of the objective dose of dialysis, as well as in the water and sodium balance. The cause of chronic kidney disease (CKD) does not seem to influence the cleansing effectiveness of the technique.
机译:背景:为了降低心血管风险,腹膜透析(PD)的发病率和死亡率,需要最小水平的小溶质清除率以及钠和水平衡。组合使用的腹膜透析液可减少并发症并允许腹膜的长期功能,而腹膜透析(PD)患者的残余肾功能(RRF)的保留对于维持生活质量至关重要和长期生存。这项回顾性队列研究回顾了我们在自动腹膜透析(APD)患者中的经验,与不同的非糖尿病性肾病(NDN)相比,糖尿病性肾病(DN)继发于终末期肾脏疾病(ESRD)。设计:包括52例糖尿病患者和29例非糖尿病患者。随访期为24个月,因此可以作为他们自己的对照。结果:肾脏尿素清除率(Kt)相对于分布体积(V)(或总体内水)(Kt / V)的比例,或肌酐清除率相对于总Kt / V或肌酐清除率(CrCl)随损失而降低RRF。 DN患者中RRF斜率的损失比NDN患者更为明显,尤其是在基线时间间隔至12个月时(分别为0.29 mL /月与0.13 mL /月的损失),并在12至24个月(分别为0.13 mL /月与0.09 mL /月的损失)。与非糖尿病患者相比,糖尿病患者的尿量减少也更大,这是从较高的基线尿量开始的。在随访期间,两组的净水平衡均足够。关于钠的平衡,在随访期间未观察到钠排泄的组间差异。此外,尿液中钠的去除随着肾功能的丧失而降低。两组中循环器中葡萄糖的平均浓度增加(DN:基线1.44±0.22,12个月1.63±0.39,24个月1.73±0.47; NDN:基线1.59±0.40,12个月1.76±0.47,24个月1.80±0.46 ),以维持净水平衡。研究参数的白天停留时间,一天的比例和肾脏的比例在随访时间内可提供持续的获益,超过30%。结论:湿日和残余肾功能是实现目标透析剂量以及水和钠平衡的决定因素。慢性肾脏疾病(CKD)的病因似乎并未影响该技术的清洁效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号